The causal relationship between HIV and AIDS was established in the mid-1980s. In 2008, French researchers won a Nobel Prize ...

With the help of new scientific and technological developments, the HIV/Aids research community is increasingly turning to an ...

Scientists have developed Lenacapavir, a twice-yearly injection that cuts HIV infection risk by 96% in groundbreaking trials.

A first-of-its-kind treatment center aimed at helping those living with or at risk of HIV is now open in Minneapolis.

A man who has lived with HIV for 12 years is part of a campaign to raise awareness of the stigma associated with the ...

In two mid-Michigan school districts where the HIV education curriculum was discovered to be out of date a year ago by 6 News ...

Lenacapavir, a new twice-yearly injection, offers 96% HIV prevention efficacy, surpassing daily oral PrEP. For oral ...

Photo: Courtesy of PASADA Tanzania. PASADA Tanzania staff participating in the World AIDS Day demonstration held in Dar es ...

Ending AIDS as a public health threat by 2030 is a real possibility, tantalizingly close. But the job is not yet done.

Nearly 200 people living with HIV across South east London have been helped back into life-saving care as part of an NHS ...

Argentines living with HIV/AIDS and medics say spending cuts under libertarian President Javier Milei are hurting treatment ...

The National AIDS Memorial has honored Dan Bernal, UCSF vice chancellor for community and government relations, for his ...